UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D. C. 20549

                                  FORM 10-KSB/A

                Annual Report Pursuant to Section 13 or 15 (d) of
                      the Securities Exchange Act of 1934

For the fiscal year ended December 31, 1995       Commission file number 0-23512

                                 BIOCORAL, INC.
           (Name of small business issuer as specified in its charter)

         Delaware                                             33-0601504
(State or other jurisdiction of                       (I.R.S. Employer I.D. No.)
 incorporation or organization)

c/o Stein Riso Haspel & Jacobs LLP,
 805 Third Avenue, New York, NY                                     10022
  (Address of Principal Executive Offices)                       (Zip Code)

                                 (212) 752-7118
                         (Registrant's telephone number)

        Securities registered pursuant to Section 12(b) of the Act: None

           Securities registered pursuant to Section 12(g) of the Act:

                               Title of each class

                          Common Stock. $.001 Par Value

      Indicate by check mark whether the issuer (1) filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the past 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days. Yes No X

      Indicate by check mark if disclosure of delinquent filers pursuant to Item
405 of Regulation S-B is not contained herein, and no disclosure will be
contained, to the best of issuer's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-KSB or any
amendment to this Form 10-KSB.

      Issuer's revenues for its most recent fiscal year were $ 1,095,489.

      The aggregate market value of the voting stock held by non-affiliates of
the Issuer, as of November 1, 1996, was $30,758,266.

      The Issuer had 5,432,041 shares of common stock outstanding as of November
1, 1996.


                                        1


<PAGE>

Item 13. Exhibits

            *10.18 Distribution Agreement between Inoteb, S.A. and 3H Human
                   Health Hightech, Ltd., dated May 13, 1995 (English and French
                   versions).

*    Filed herewith.

<PAGE>

            SIGNATURES

            Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the Company has duly caused this amendment to
be signed on its behalf by the undersigned, thereunto duly authorized.

                                            BIOCORAL, INC.


Date: 8/5/99                                By: /s/ Nasser Nassiri
                                                --------------------------------
                                                    Nasser Nassiri, Chairman of
                                                    the Board and Chief
                                                    Executive Officer

            Pursuant to the requirements of the Securities Exchange Act of 1934,
this report has been signed below by the following persons on behalf of the
Company and in the capacities and on the dates indicated.

Signature                         Title                               Date
---------                         -----                               ----


/s/ Nasser Nassiri
-------------------
Nasser Nassiri                    Chairman of the Board               8/5/99
                                  and a director


/s/ Ramine Almassi
------------------
Ramine Almassi                    Treasurer, Secretary and            8/5/99
                                  a director


/s/ Jean Darondel                 Director                            8/5/99
------------------
Jean Darondel


                                       24